
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafu... Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.38 | -24.6675836772 | 21.81 | 22.64 | 16.3525 | 124108 | 19.30591868 | CS |
4 | -5.42 | -24.8054919908 | 21.85 | 24.14 | 16.3525 | 158063 | 21.88280214 | CS |
12 | -8.36 | -33.7232755143 | 24.79 | 25.7774 | 16.3525 | 120226 | 21.90848825 | CS |
26 | 5.73 | 53.5514018692 | 10.7 | 28.42 | 10.14 | 90985 | 21.51098606 | CS |
52 | -4.57 | -21.7619047619 | 21 | 28.42 | 10.004 | 131314 | 17.28422845 | CS |
156 | -2.17 | -11.6666666667 | 18.6 | 42 | 8 | 685330 | 22.95665 | CS |
260 | -33.37 | -67.0080321285 | 49.8 | 89 | 8 | 606119 | 29.46270332 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales